Document Detail


Modulation of doxorubicin sensitivity by a novel organic compound, oxalyl bis (N-phenyl) hydroxamic acid on acetyl aminofluorene-induced preneoplastic hepatocytes.
MedLine Citation:
PMID:  14643023     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Development of biochemical modulators and application of the same with anticancer drugs is a current approach of modern cancer chemotherapy. We report the effect of two novel hydroxamic acid derivatives, viz. oxaly bis (N-phenyl) hydroxamic acid (OBPHA) and succinyl bis (N-phenyl) hydroxamic acid (SBPHA) on doxorubicin sensitivity and on P-glycoprotein (P-gp) in acetyl amino fluorene (AAF) induced preneoplastic hepatocytes in vitro. OBPHA increases doxorubicin sensitivity in AAF induced preneoplastic hepatocytes compared to normal hepatocytes. SBPHA, with an additional -CH(2)-CH(2)- group than OBPHA does not modulate the sensitivity of doxorubicin. The mechanism of action of OBPHA and SBPHA and their in vivo toxicity on male Swiss mice has been studied. OBPHA in combination with doxorubicin (i.e. OBPHA+doxorubicin) has higher antitumour activity compared to doxorubicin alone group; in consequence, OBPHA may decrease the dose related side effect of doxorubicin.
Authors:
S K Choudhuri; Surajit Majumder
Related Documents :
6470513 - Structure-activity relationships of retinoids in the morphogenesis of cutaneous appenda...
3045163 - Topical tretinoin in the treatment of aging skin.
21367203 - 220 relationship between follicular fluid metabolome and bovine oocyte developmental co...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Cancer letters     Volume:  202     ISSN:  0304-3835     ISO Abbreviation:  Cancer Lett.     Publication Date:  2003 Dec 
Date Detail:
Created Date:  2003-12-03     Completed Date:  2004-02-03     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7600053     Medline TA:  Cancer Lett     Country:  Ireland    
Other Details:
Languages:  eng     Pagination:  25-34     Citation Subset:  IM    
Affiliation:
Department of Environmental Carcinogenesis and Toxicology, Chittaranjan National Cancer Institute, 37, S.P. Mukherjee Road, Calcutta 700026, India. soumitra01@vsnl.net
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
2-Acetylaminofluorene / toxicity*
Animals
Antibiotics, Antineoplastic / therapeutic use*
Benzeneacetamides / therapeutic use*
Calcium Channel Blockers / pharmacology
Carcinogens / toxicity
Cell Division / drug effects
Dose-Response Relationship, Drug
Doxorubicin / therapeutic use*
Drug Synergism
Drug Therapy, Combination
Glutathione / metabolism
Hepatocytes / drug effects*,  metabolism,  pathology
Humans
Hydroxamic Acids / therapeutic use*
Male
Mice
Oxalates / therapeutic use*
P-Glycoprotein / metabolism
Precancerous Conditions / chemically induced,  drug therapy*,  metabolism
Rats
Rats, Sprague-Dawley
Spleen / metabolism
Survival Rate
Tumor Cells, Cultured
Verapamil / pharmacology
Chemical
Reg. No./Substance:
0/Antibiotics, Antineoplastic; 0/Benzeneacetamides; 0/Calcium Channel Blockers; 0/Carcinogens; 0/Hydroxamic Acids; 0/Oxalates; 0/P-Glycoprotein; 0/oxalyl bis(N-phenyl)hydroxamic acid; 23214-92-8/Doxorubicin; 52-53-9/Verapamil; 53-96-3/2-Acetylaminofluorene; 70-18-8/Glutathione

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Expression of CYP3A4 in human breast tumour and non-tumour tissues.
Next Document:  Protoporphyrin IX-accumulation in human tumor cells following topical ALA- and h-ALA-application in ...